PHX

0.00%

4.7¢ pharmx technologies limited

COO half year results and trading volumes, page-17

First 17 Last

Share
Profile

Follow
Parma

2,824 Posts.

234

05/02/18

17:38

Post #: 30832822
Share

Originally posted by roboshan ↑

Totally appreciate your cynicism spider! Most of us have been confused and somewhat disappointed that management has had this substantial cash holding doing very little for many years. Perhaps it is just being over cautious waiting for the perfect compatible opportunity that will bring immediate returns, however this could mean they miss the boat.

In the mean time they have concentrated on their core business by investing in new improved products and services. In addition they have been improving internal business systems that create operational efficiencies. From there they now have the ability to implement cost structures that are more in balance with income streams and thus return the company to acceptable profitability. Given the changes to their marketplace (group consolidation and reduction customer base) this is an appropriate strategy to safeguard the businesses viability.

Management has decided not to invest in their payment services business which has also seen a substantial income decline. Lack of innovation here has see others penetrate their market but have they tried hard enough to find new markets (e.g. payment service for college fees, sports club subscriptions, fund raising, etc - all happening in recent years). With this side of the business declining it is taking away diversification of income streams.

While I firstly favour consolidation by M & A in the pharmacy software arena and the synergy here, perhaps opportunity exists for Corum to invest in or develop a partnerships outside of pharmacy and payment software and services. By all means, if possible stay in healthcare software and services where there is obviously growth potential but don't discount other areas, as a well run profitable business is what it is.

The Half Yearly is coming soon and will be definitive as to how well and timely the current strategy is working. It would be nice to see the decline in revenues halted, a significant reduction in expenses and improved profitability. If this occurs we should see the return to paying a dividend.... the cash is available.

Expand

If the Half Yearly disappoints this going sub .01 cent.
Great opportunity for a Management buy out eh???

COO Price at posting: 3.4¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

First 17 Last

Add PHX (ASX) to my watchlist

(20min delay)
Last 4.7¢		Change 0.000(0.00%)		Mkt cap ! $28.12M

Open	High	Low	Value	Volume
4.7¢	4.7¢	4.7¢	$940	20K

Buyers (Bids)

No.	Vol.	Price($)
1	83300	4.4¢

Sellers (Offers)

Price($)	Vol.	No.
4.7¢	174999	3

View Market Depth

No.	Vol.	Price($)
1	83300	0.044
1	78187	0.043
1	13940	0.042
1	137600	0.041
1	165000	0.040

Price($)	Vol.	No.
0.047	174999	3
0.050	324438	3
0.055	555000	3
0.057	500000	1
0.080	50000	1

Last trade - 10.06am 04/10/2024 (20 minute delay)

PHX (ASX) Chart

COO half year results and trading volumes, page-17

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

COO half year results and trading volumes, page-17

Top Stories

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News